Table 1 Demographics and baseline characteristics of study subjects, Study 1 (FTIH)
Cohorts 1 and 2 | Cohorts 3 and 4 | Cohort 5 | ||||
|---|---|---|---|---|---|---|
Placebo RD | danirixin 50 mg RD | danirixin 200 mg RD | Placebo SD | danirixin 400 mg SD | ||
Age, yrs mean (SD) | 35 (13) | 35 (8) | 29 (10) | 33 (14) | 27 (5) | 25 (4) |
n, (% male) | 30 (100 %) | 8 (100 %) | 10 (100 %) | 10 (100 %) | 5 (100 %) | 10 (100 %) |
Race, n (%) | ||||||
White | 25 (83) | 6 (75) | 10 (100) | 9 (90) | 4 (80) | 7 (70) |
African-American | 3 (10) | 2 (25) | 0 | 0 | 1 (20) | 1 (10) |
Asian | 2 (6) | 0 | 0 | 1(10) | 0 | 2 (20) |
BMI (kg/m2) mean (SD) | 25 (2) | 26 (3) | 25 (2) | 25 (3) | 24 (4) | 24 (2) |